Loading...
The use of apatinib in treating primary pleural synovial sarcoma: A case report
RATIONALE: Apatinib is an oral tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2. It has been shown that apatinib is effective and safe for treatment of multiple solid tumors, including gastric cancer, liver cancer, non-small-cell lung cancer, and breast cancer. Howev...
Na minha lista:
| Udgivet i: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6940042/ https://ncbi.nlm.nih.gov/pubmed/31861000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000018382 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|